Literature DB >> 7071817

HLA and alcoholic cirrhosis.

B D Tait, I R Mackay.   

Abstract

In fifty-seven patients with alcoholic cirrhosis the frequency of HLA-DR2 was found to be 47.4%, in contrast to 26.1% in 119 normal subjects and 14.0% in 43 cases of autoimmune-type chronic active hepatitis (CAH). The frequencies of HLA-DR3 in the three respective groups also differed, being 24.6%, 31.9% and 74.4%. The greatly differing HLA-DR profiles in alcoholic cirrhosis and CAH point to immunogenetic differences in predisposition to these two liver diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071817     DOI: 10.1111/j.1399-0039.1982.tb01410.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

Review 1.  Genetic predisposition to alcoholic liver disease.

Authors:  C P Day; M F Bassendine
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

2.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

3.  Greater hepatic vulnerability after alcohol intake in African Americans compared with Caucasians: a population-based study.

Authors:  Saverio Stranges; Jo L Freudenheim; Paola Muti; Eduardo Farinaro; Marcia Russell; Thomas H Nochajski; Maurizio Trevisan
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

4.  Histocompatibility antigens in patients with alcoholic liver disease in Scotland and northeastern England: failure to show an association.

Authors:  P R Mills; R N MacSween; H M Dick; W S Hislop
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  Hepatic cirrhosis in young adults: association with adolescent onset of alcohol and parenteral heroin abuse.

Authors:  D M Novick; R W Enlow; A M Gelb; R J Stenger; M Fotino; J W Winter; S R Yancovitz; M D Schoenberg; M J Kreek
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.